Chief Executive Officer

Patrick Mehlen is director of the Institut Rabelais for Interdisciplinary Research on Cancer, director of the “Laboratoire d’Excellence” DEVweCAN, director of the Research Cancer Center of Lyon, director of the Department of Translational Research and Innovation in Léon Bérard Comprehensive Cancer Center in Lyon, France and co-founder & CEO of NETRIS Pharma.
He is Adjunct Professor at the Buck Institute for Age Research, California. He has published over 150 peer-reviewed scientific publications and has received several awards including the silver medal from CNRS and the Pius XI Gold Medal from Pontificia Academia Scientiarum.
Prof. Mehlen was elected EMBO member in 2006 and member of the French Academy of Sciences in 2013.